Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Innopharma (Piscataway, NJ) a development-stage specialty pharmaceutical company focused on generics and drug delivery technology platforms for existing drugs, closed a $15M Series A financing. Participants include Thomas, McNerney & Partners.

Novast Pharmaceuticals (China) a vertically integrated generics, manufacturing and R&D focused entity closed a $25M Series C financing. Participants include SAIF Partners, New Enterprise Associates, Qiming Ventures, Lilly Ventures and BioVeda Capital.

Itero Biopharmaceuticals (San Mateo, CA) focused on novel and follow-on protein and antibody therapeutics, closed a $21M Series A financing. Participants include SV Life Sciences, Panorama Capital and VenturEast.

Heritage Pharmaceuticals (Edison, NJ) commercial-stage generic pharmaceutical company closed a $10M Series A financing. Participants include McClendon Venture Company and TLW Ventures.

  

to top of page...